• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情后初级保健就诊对改善多病共存超高龄患者生存的效果:全港范围目标试验模拟。

Effectiveness of post-COVID-19 primary care attendance in improving survival in very old patients with multimorbidity: a territory-wide target trial emulation.

机构信息

Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong.

Department of Health Services Research and Policy, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.

出版信息

Fam Med Community Health. 2024 Jul 14;12(3):e002834. doi: 10.1136/fmch-2024-002834.

DOI:10.1136/fmch-2024-002834
PMID:39004436
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11253766/
Abstract

OBJECTIVES

Older individuals with multimorbidity are at an elevated risk of infection and complications from COVID-19. Effectiveness of post-COVID-19 interventions or care models in reducing subsequent adverse outcomes in these individuals have rarely been examined. This study aims to examine the effectiveness of attending general outpatient within 30 days after discharge from COVID-19 on 1-year survival among older adults aged 85 years or above with multimorbidity.

DESIGN

Retrospective cohort study emulating a randomised target trial using electronic health records.

SETTING

We used data from the Hospital Authority and the Department of Health in Hong Kong, which provided comprehensive electronic health records, COVID-19 confirmed case data, population-based vaccination records and other individual characteristics for the study.

PARTICIPANTS

Adults aged 85 years or above with multimorbidity who were discharged after hospitalisation for COVID-19 between January 2020 and August 2022.

INTERVENTIONS

Attending a general outpatient within 30 days of last COVID-19 discharge defined the exposure, compared to no outpatient visit.

MAIN OUTCOME MEASURES

Primary outcome was all-cause mortality within one year. Secondary outcomes included mortality from respiratory, cardiovascular and cancer causes.

RESULTS

A total of 6183 eligible COVID-19 survivors were included in the analysis. The all-cause mortality rate following COVID-19 hospitalisation was lower in the general outpatient visit group (17.1 deaths per 100 person-year) compared with non-visit group (42.8 deaths per 100 person-year). After adjustment, primary care consultations within 30 days after discharge were associated with a significantly greater 1-year survival (difference in 1-year survival: 11.2%, 95% CI 8.1% to 14.4%). We also observed significantly better survival from respiratory diseases in the general outpatient visit group (difference in 1-year survival: 6.3%, 95% CI 3.5% to 8.9%). In a sensitivity analysis for different grace period lengths, we found that the earlier participants had a general outpatient visit after COVID-19 discharge, the better the survival.

CONCLUSIONS

Timely primary care consultations after COVID-19 hospitalisation may improve survival following COVID-19 hospitalisation among older adults aged 85 or above with multimorbidity. Expanding primary care services and implementing follow-up mechanisms are crucial to support this vulnerable population's recovery and well-being.

摘要

目的

患有多种合并症的老年人感染 COVID-19 并出现并发症的风险较高。针对这些人,COVID-19 后干预或护理模式在降低后续不良结局方面的有效性很少被研究。本研究旨在调查 COVID-19 出院后 30 天内到普通门诊就诊对 85 岁及以上患有多种合并症的老年人 1 年生存率的影响。

设计

使用电子健康记录模拟随机对照试验的回顾性队列研究。

地点

我们使用了来自香港医院管理局和卫生署的数据,这些数据提供了全面的电子健康记录、COVID-19 确诊病例数据、基于人群的疫苗接种记录和其他个体特征。

参与者

2020 年 1 月至 2022 年 8 月期间因 COVID-19 住院后出院的 85 岁及以上患有多种合并症的成年人。

干预措施

COVID-19 出院后 30 天内到普通门诊就诊定义为暴露,与未就诊相比。

主要结局测量指标

主要结局为 1 年内全因死亡率。次要结局包括因呼吸、心血管和癌症导致的死亡。

结果

共有 6183 名符合条件的 COVID-19 幸存者纳入分析。与非就诊组(每 100 人年 42.8 例死亡)相比,普通门诊就诊组 COVID-19 住院后的全因死亡率较低(每 100 人年 17.1 例死亡)。调整后,出院后 30 天内的初级保健咨询与 1 年生存率显著提高相关(1 年生存率差异:11.2%,95%CI 8.1%至 14.4%)。我们还观察到普通门诊就诊组的呼吸系统疾病生存率显著提高(1 年生存率差异:6.3%,95%CI 3.5%至 8.9%)。在不同宽限期长度的敏感性分析中,我们发现 COVID-19 出院后参与者越早到普通门诊就诊,生存率越高。

结论

COVID-19 住院后及时进行初级保健咨询可能会提高 85 岁及以上患有多种合并症的老年人 COVID-19 住院后的生存率。扩大初级保健服务并实施后续机制对于支持这一脆弱人群的康复和福祉至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f2/11253766/5b867cfb4296/fmch-12-3-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f2/11253766/693102a97aca/fmch-12-3-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f2/11253766/77d68975512e/fmch-12-3-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f2/11253766/9f2a1379ab69/fmch-12-3-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f2/11253766/5b867cfb4296/fmch-12-3-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f2/11253766/693102a97aca/fmch-12-3-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f2/11253766/77d68975512e/fmch-12-3-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f2/11253766/9f2a1379ab69/fmch-12-3-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f2/11253766/5b867cfb4296/fmch-12-3-g004.jpg

相似文献

1
Effectiveness of post-COVID-19 primary care attendance in improving survival in very old patients with multimorbidity: a territory-wide target trial emulation.新冠疫情后初级保健就诊对改善多病共存超高龄患者生存的效果:全港范围目标试验模拟。
Fam Med Community Health. 2024 Jul 14;12(3):e002834. doi: 10.1136/fmch-2024-002834.
2
Effectiveness of post-COVID-19 primary care attendance in improving survival in very old patients with multimorbidity: a territory-wide target trial emulation.新冠疫情后初级保健就诊对改善多病共存超高龄患者生存的效果:全港范围目标试验模拟。
Br J Gen Pract. 2024 Jun 20;74(suppl 1):bjgp24X737517. doi: 10.3399/bjgp24X737517.
3
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
4
Risks of incident major osteoporotic fractures following SARS-CoV-2 infection among older individuals: a population-based cohort study in Hong Kong.新冠病毒感染后老年个体发生重大骨质疏松性骨折的风险:香港一项基于人群的队列研究。
J Bone Miner Res. 2024 May 24;39(5):551-560. doi: 10.1093/jbmr/zjae041.
5
Analysis of All-Cause Hospitalization and Death Among Nonhospitalized Patients With Type 2 Diabetes and SARS-CoV-2 Infection Treated With Molnupiravir or Nirmatrelvir-Ritonavir During the Omicron Wave in Hong Kong.奥密克戎变异株流行期间,未住院的 2 型糖尿病合并 SARS-CoV-2 感染患者接受莫努匹韦或奈玛特韦/利托那韦治疗后的全因住院和死亡分析。
JAMA Netw Open. 2023 May 1;6(5):e2314393. doi: 10.1001/jamanetworkopen.2023.14393.
6
A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.一项针对高风险确诊严重 SARS-CoV-2 疾病患者的随机开放标签 II 期临床试验,比较 SARS-CoV-2 感染后恢复期患者输注血浆与未输注血浆的疗效(RECOVER):一项随机对照试验的研究方案的结构化总结。
Trials. 2020 Oct 6;21(1):828. doi: 10.1186/s13063-020-04735-y.
7
Impact of COVID-19 on loneliness, mental health, and health service utilisation: a prospective cohort study of older adults with multimorbidity in primary care.COVID-19 对孤独感、心理健康和卫生服务利用的影响:初级保健中老年多病患者的前瞻性队列研究。
Br J Gen Pract. 2020 Oct 29;70(700):e817-e824. doi: 10.3399/bjgp20X713021. Print 2020 Nov.
8
Multimorbidity and adverse events of special interest associated with Covid-19 vaccines in Hong Kong.香港与新冠病毒疫苗相关的多种合并症和特殊关注不良事件。
Nat Commun. 2022 Jan 20;13(1):411. doi: 10.1038/s41467-022-28068-3.
9
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
10
Use, satisfaction, and preference of online health services among older adults with multimorbidity in Hong Kong primary care during COVID-19.在 COVID-19 期间,香港基层医疗中老年多病患者对在线健康服务的使用、满意度和偏好。
BMC Geriatr. 2023 Jun 15;23(1):368. doi: 10.1186/s12877-023-04061-3.

本文引用的文献

1
Updated Clinical Practice Guidelines for the Diagnosis and Management of Long COVID.《长新冠诊断与管理的更新临床实践指南》
Infect Chemother. 2024 Mar;56(1):122-157. doi: 10.3947/ic.2024.0024. Epub 2024 Mar 13.
2
Neurological manifestations of COVID-19 in Indonesia: Assessment of the role of sex and age.印度尼西亚新冠肺炎的神经学表现:性别和年龄作用的评估
Narra J. 2023 Dec;3(3):e277. doi: 10.52225/narra.v3i3.277. Epub 2023 Dec 20.
3
WHO declares end to COVID-19's emergency phase.世界卫生组织宣布新冠疫情紧急阶段结束。
Nature. 2023 May 5. doi: 10.1038/d41586-023-01559-z.
4
Comorbidities, multimorbidity and COVID-19.合并症、多重疾病与2019冠状病毒病
Nat Med. 2023 Feb;29(2):334-343. doi: 10.1038/s41591-022-02156-9. Epub 2023 Feb 16.
5
Booster vaccination with inactivated whole-virus or mRNA vaccines and COVID-19-related deaths among people with multimorbidity: a cohort study.加强针接种灭活全病毒疫苗或 mRNA 疫苗与合并多种基础疾病人群的 COVID-19 相关死亡:一项队列研究。
CMAJ. 2023 Jan 30;195(4):E143-E152. doi: 10.1503/cmaj.221068.
6
Long COVID: An opportunity to focus on post-acute infection syndromes.长期新冠:关注急性感染后综合征的契机。
Lancet Reg Health Eur. 2022 Nov 1;22:100540. doi: 10.1016/j.lanepe.2022.100540. eCollection 2022 Nov.
7
Target Trial Emulation: A Framework for Causal Inference From Observational Data.目标试验模拟:一种从观察性数据进行因果推断的框架。
JAMA. 2022 Dec 27;328(24):2446-2447. doi: 10.1001/jama.2022.21383.
8
Patient outcomes following emergency admission to hospital for COVID-19 compared with influenza: retrospective cohort study.因 COVID-19 紧急住院治疗的患者结局与流感的比较:回顾性队列研究。
Thorax. 2023 Jul;78(7):706-712. doi: 10.1136/thoraxjnl-2021-217858. Epub 2022 Jul 27.
9
A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action.一项关于 COVID-19 大流行长期身心后遗症的系统回顾和荟萃分析:呼吁研究重点和行动。
Mol Psychiatry. 2023 Jan;28(1):423-433. doi: 10.1038/s41380-022-01614-7. Epub 2022 Jun 6.
10
The effectiveness of pulmonary rehabilitation for Post-COVID symptoms: A rapid review of the literature.肺康复对新冠后症状的有效性:文献快速综述
Respir Med. 2022 Mar 2;195:106782. doi: 10.1016/j.rmed.2022.106782.